Relmada Therapeutics, Inc.

Historical 13F Holders

Symbol
RLMD
CUSIP
75955J402
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 75955J402 since 12/18/2024, largest first.

Filer % of Class Filed
Janus Henderson Group PLC 13G 10.1% 2/6/2026
Event 1/30/2026
BlackRock, Inc. 13G 7.0% 7/29/2026
Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P. 13G
6.2% 6/9/2026
Event 6/2/2026
Spruce Street Capital LP 13G
5.6% 2/17/2026
Event 12/31/2025
Commodore Capital LP 13G
5.1% 5/4/2026
Event 4/27/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Ikarian Capital, LLC 13G
4.8% 11/14/2025
Event 9/30/2025
Adage Capital Management, L.P. 13G/A
4.5% 5/13/2026
Event 3/31/2026
Millennium Management LLC 13G
4.4% 6/22/2026
Event 6/16/2026
Squadron Capital Management LLC 13G/A
3.3% 11/16/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 135 104 M $394M
2026 Q2 127 100 M $694M
2026 Q1 104 84.7 M $589M
2025 Q4 80 51.6 M $249M
2025 Q3 46 7.74 M $15.5M
2025 Q2 52 5.31 M $3.18M
2025 Q1 46 6.22 M $1.68M
2024 Q4 53 8.40 M $4.36M
2024 Q3 72 12.4 M $40.2M
2024 Q2 81 13.6 M $40.7M
2024 Q1 94 14.3 M $66.5M
2023 Q4 84 13.6 M $56.4M
2023 Q3 89 15.0 M $45.0M
2023 Q2 97 16.1 M $39.7M
2023 Q1 92 17.8 M $40.3M
2022 Q4 116 19.1 M $66.8M
2022 Q3 145 25.8 M $954M
2022 Q2 124 24.7 M $468M
2022 Q1 119 23.1 M $623M
2021 Q4 98 20.7 M $467M
2021 Q3 88 10.0 M $263M
2021 Q2 88 9.94 M $318M
2021 Q1 84 9.54 M $336M
2020 Q4 82 9.31 M $299M
2020 Q3 76 10.4 M $393M
2020 Q2 78 10.5 M $469M
2020 Q1 44 9.36 M $319M
2019 Q4 48 6.80 M $265M
2019 Q3 1 0 $0